Cognibiome therapeutics, inc.. smart gut. sharper mind.
CogniBiome Therapeutics is developing microbiota-derived therapeutics that enhance cognitive performance, build cognitive resilience, prevent cognitive decline and dementia, and slow Alzheimer’s disease progression. We identify and harness human-validated microbial functional states that optimize brain performance and protect against cognitive decline, dementia, and Alzheimer’s disease. Our platform supports both performance enhancement and disease-modifying therapeutic programs.
CogniBiome Is Not: • Not a supplement or nootropic company • Not a diet or nutrition company • Not a probiotic lottery • Not a single-disease Alzheimer’s company
CogniBiome Is: • A therapeutics platform spanning: o Cognitive performance o Cognitive resilience o Prevention of cognitive decline and dementia o Slowing Alzheimer’s progression • Built on novel microbiota IP • Designed for drug-like development, partnering, and scale • Including, but not limited to, next generation oral capsule delivery approaches • Including, but not limited to, Mediterranean diet-derived compositions
About CogniBiome Therapeutics
CogniBiome Therapeutics is identified as a technology offering listed within the Tulane University Flintbox portal. The technology relates to advancements in biomedical research, specifically in the development of therapeutic approaches for clinical and research applications. As a listed technology in the university's intellectual property and innovation transfer ecosystem, it is positioned for potential licensing or partnership with industry developers and research collaborators interested in advancing these specific medical technologies.
This technology initiative serves to bridge academic research with practical medical applications, addressing specific health challenges through innovative compounds or treatment methodologies. By providing a framework for intellectual property protection and commercialization, the university facilitates the transition of such early-stage therapeutics from the laboratory setting toward broader development and testing phases, aiming to solve unmet medical needs through targeted therapeutic innovation.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.